Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Sequential Multiple-Dose Regimens of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

NCT01376076 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01376076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01376076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Sequential Multiple-Dose Regimens of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia
Lead sponsor
Forest Laboratories
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2011
Completion date
February 29, 2012
Enrollment
129 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia